A Study of LY3209590 in Japanese Participants With Type 2 Diabetes
Status:
Completed
Trial end date:
2019-05-27
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety of a study drug known as LY3209590
in Japanese participants with type 2 diabetes. Side effects and tolerability will be
documented. Blood samples will be taken to compare how the body handles the drug and how it
affects blood sugar levels. The study will last about four weeks, not including screening.
Screening is required within 4 weeks before the start of the study.